Dr. Milton Harris, Serina Therapeutics Board Chairman and HudsonAlpha Board Member, was awarded the Per-Åke Albertsson Award for his life-long work in Bio-partitioning and Purification of Aqueous Polymer two-phase systems. Dr. Harris will receive the award at BPP 2022 in Aveiro, Portugal at the end of September. 

Dr. Per-Åke Albertsson was a Swedish Biochemist, Educator and a Member of the Royal Swedish Academy of Sciences. In his memory, this award is given to exemplary scientists who have contributed in the field of separation sciences.  

Dr. Milton Harris founded Shearwater Polymers, Inc. in 1992 to advance polyethylene glycol “PEG” technology.  The company later became Nektar Therapeutics. Dr. Harris co-founded Serina Therapeutics in 2006 and joined the Board of the HudsonAlpha Institute for Biotechnology at the same time. Dr. Harris is also the recipient of the Nagai Innovation Award (2005, Controlled Release Society) and a member of the Swedish Academy of Engineering Sciences.